Metipranolol
Back to searchMolecule Structure
Scientific Name
Metipranolol
Description of the Drug
Metipranolol is a beta-adrenergic antagonist used for the reduction of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01214
http://www.drugbank.ca/drugs/DB01214
Brand Name(s)
Glauline, Optipranolol
Company Owner(s)
Sandoz Inc, Bausch And Lomb Pharmaceuticals Inc
Mechanism(s) Of Action
Target Name | Target Type | Action Type | Target ChEMBL ID |
---|---|---|---|
Beta-1 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL213 |
Beta-2 adrenergic receptor | SINGLE PROTEIN | ANTAGONIST | CHEMBL210 |
Clinical Trial(s)
Unichem Links
SureChEMBL | SCHEMBL24324 | |
PharmGKB | PA164748727 | |
Human Metabolome Database | HMDB0015345 | |
DrugBank | DB01214 | |
PubChem: Thomson Pharma | 14923317 | |
PubChem | 31477 | |
Mcule | MCULE-4113586715 | |
Nikkaji | J11.486C | |
EPA CompTox Dashboard | DTXSID4046078 | |
DrugCentral | 1779 | |
ChemicalBook | CB2880767 | |
Guide to Pharmacology | 7239 | |
rxnorm | METIPRANOLOL | METIPRANOLOL HYDROCHLORIDE |
KEGG Ligand | C07915 | |
ChEBI | 6897 |